Intravenous immunoglobulin-induced acute thrombocytopenia.

about

Intravenous immunoglobulin-induced acute thrombocytopenia.

Item

http://www.wikidata.org/entity/Q48203712

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Intravenous immunoglobulin-induced acute thrombocytopenia.

@en

Intravenous immunoglobulin-induced acute thrombocytopenia.

@nl

type

Item

label

Intravenous immunoglobulin-induced acute thrombocytopenia.

@en

Intravenous immunoglobulin-induced acute thrombocytopenia.

@nl

prefLabel

Intravenous immunoglobulin-induced acute thrombocytopenia.

@en

Intravenous immunoglobulin-induced acute thrombocytopenia.

@nl

P1476

Intravenous immunoglobulin-induced acute thrombocytopenia.

@en

P2093

Boaz Tadmor

http://www.w3.org/2001/XMLSchema#string

Galia Spectre

http://www.w3.org/2001/XMLSchema#string

Lilach Bonstein

http://www.w3.org/2001/XMLSchema#string

Michael Shapiro

http://www.w3.org/2001/XMLSchema#string

Nardeen Atweh

http://www.w3.org/2001/XMLSchema#string

Pia Raanani

http://www.w3.org/2001/XMLSchema#string

Tsipora Gruenewal

http://www.w3.org/2001/XMLSchema#string

P2860

Laboratory testing for platelet antibodies

Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.

On the dark side of therapies with immunoglobulin concentrates: the adverse events

Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases.

Effort-reward imbalance and perceived quality of patient care: a cross-sectional study among physicians in Germany.

Advances in the understanding of the mechanism of action of IVIg.

Intravenous immunoglobulin: adverse reactions and management.

The pro and anti-inflammatory activities of immunoglobulin G.

Relevant criteria for selecting an intravenous immunoglobulin preparation for clinical use.

Hematologic toxicities associated with intravenous immunoglobulin therapy.

P304

493-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.14419

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anna Gurevich-Shapiro

P577

2017-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29193103

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia